Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Single Arm, Observational Study to Evaluate the Safety of Linaclotide in IBS-C Patients in China

NCT04462900 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04462900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04462900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Single Arm, Observational Study to Evaluate the Safety of Linaclotide in IBS-C Patients in China
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 18, 2020
Completion date
February 3, 2023
Enrollment
3,028 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome-ibs